CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
MG-1device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01528319
NCT01528319N/ACompleted

Open Clinical Trial of Arthroscopic Bankart Repair Using MG-1 for Dislocation of the Shoulder

Johnson & Johnson K.K. Medical Company·interventional·Posted Feb 8, 2012·Updated Aug 4, 2014

In Brief

A clinical study evaluating MG-1 for Shoulder Dislocation. Completed, enrolled 24 participants across 2 sites.

Detailed Summary

To evaluate the efficacy and safety of arthroscopic Bankart repair using MG-1 for dislocation of shoulder

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 8, 2012
Enrollment StartDec 1, 2011
Primary CompletionAug 1, 2012
Study CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.4 years ago

Interventions

MG-1device

Being embedded in the area of glenohumeral instability by arthroscopic Bankart repair method.